Prosecution Insights
Last updated: August 06, 2026

Gunn, Lee & Cave, P.C.

8 pending office actions • 7 clients • 8 examiners • 6 art units • 0 of 8 (0%) have an AI response strategy ready

Quality Metrics (n=885 apps, methodology: how we score firms)

91.8%
Allowance Rate
n=885
+0.59σ
Allowance Rate (norm)
n=885
2.7
OAs to Allowance
n=608
-0.53σ
OAs to Allow (norm)
n=608
961 days
Time to Allowance
n=608
+4.1pp
Interview Lift
n=885
17.1%
RCE Rate
n=885
0.9%
Appeal Rate
n=885

Rejection Performance (% of received rejections ultimately overcome)

90.9%
§101 Overcome
n=33
83.8%
§102 Overcome
n=191
87.1%
§103 Overcome
n=309
89.9%
§112 Overcome
n=248

Specialization & Scale

E21B, G01N, Y10T
Top CPC Subclasses
11%
Top-3 CPC Share
n=885
3
Practitioners
n=885
295.0
Apps / Practitioner
n=885

Portfolio Summary

8
Total Pending OAs
7
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (50%)
3
Medium (38%)
0
Easy (0%)
1
Unknown (12%)

Rejection Statute Mix

BucketCases
§101 only1 (12%)
§103 only2 (25%)
§102 only1 (12%)
Multi-statute (no §101)3 (38%)
No statute on record1 (12%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
12% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
4
Mechanical / Eng
50% of docket
3
Business / Other
38% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CUFF, MICHAEL A 1 82.2% +12.5%
BUTCHER, CAROLINE N 1 81.3% +13.6%
CARY, KELSEY E 1 75.0% +24.6%
HADEN, SALLY CLINE 1 32.0% +40.8%
TRAN, ERIC 1 69.8% +24.0%
AZAD, MD ABUL K 1 81.5% +20.9%
MPAMUGO, CHINYERE 1 27.6% +27.4%
QIAN, CELINE X 1 47.6% +16.6%

Quick Wins (3)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18932088 Mandrel with integrated centralizer BUTCHER, CAROLINE N 17d overdue
18999891 System and methods for timing rodeo events CUFF, MICHAEL A
18662690 Programmable Mesh Wi-fi Solar Powered Sprinkler System AZAD, MD ABUL K

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18932181 BurstGuard Check Valve CARY, KELSEY E 53d overdue
18922320 Device for Absorbing, Dissipating and Deflecting Impact Energy HADEN, SALLY CLINE
18743985 C-7 FUNCTIONALIZED ARTEMISININ DERIVATIVES FOR THE TREATMENT OF MALARIA TRAN, ERIC
18606679 Method and System for Securely Managing Transactions Between Healthcare Stakeholders MPAMUGO, CHINYERE

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18932181 BurstGuard Check Valve CARY, KELSEY E 53d overdue
18932088 Mandrel with integrated centralizer BUTCHER, CAROLINE N 17d overdue
18004158 MESOTHELIN ISOFORM BINDING MOLECULES AND CHIMERIC PD1 RECEPTOR MOLECULES, CELLS CONTAINING THE SAME AND USES THEREOF QIAN, CELINE X 14d
18999891 System and methods for timing rodeo events CUFF, MICHAEL A
18922320 Device for Absorbing, Dissipating and Deflecting Impact Energy HADEN, SALLY CLINE
18743985 C-7 FUNCTIONALIZED ARTEMISININ DERIVATIVES FOR THE TREATMENT OF MALARIA TRAN, ERIC
18662690 Programmable Mesh Wi-fi Solar Powered Sprinkler System AZAD, MD ABUL K
18606679 Method and System for Securely Managing Transactions Between Healthcare Stakeholders MPAMUGO, CHINYERE

Client Portfolio (7 clients)

Top Art Units

Art UnitApps
36761
37531
37321
41001
36851
16371

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18999891 System and methods for timing rodeo events Auto-Precision Rodeo Timers, LLC CUFF, MICHAEL A §102 Non-Final OA Pending Dec 23, 2024
18932088 Mandrel with integrated centralizer Peak Completion Technologies, Inc. BUTCHER, CAROLINE N 3676 §103 Final Rejection 17d overdue Pending Oct 30, 2024
18932181 BurstGuard Check Valve Peak Completion Technologies, Inc. CARY, KELSEY E 3753 §102§112 Non-Final OA 53d overdue Pending Oct 30, 2024
18922320 Device for Absorbing, Dissipating and Deflecting Impact Energy Gregory Andrew Grim HADEN, SALLY CLINE 3732 §102§103 Non-Final OA Pending Oct 21, 2024
18743985 C-7 FUNCTIONALIZED ARTEMISININ DERIVATIVES FOR THE TREATMENT OF MALARIA University Of The Incarnate Word TRAN, ERIC §102§103§112 Non-Final OA Pending Jun 14, 2024
18662690 Programmable Mesh Wi-fi Solar Powered Sprinkler System Rld Resources, LLC AZAD, MD ABUL K 4100 §103 Non-Final OA Pending May 13, 2024
18606679 Method and System for Securely Managing Transactions Between Healthcare Stakeholders Old Well Solutions, LLC MPAMUGO, CHINYERE 3685 §101 Non-Final OA Pending Mar 15, 2024
18004158 MESOTHELIN ISOFORM BINDING MOLECULES AND CHIMERIC PD1 RECEPTOR MOLECULES, CELLS CONTAINING THE SAME AND USES THEREOF Immunocell Therapeutics, Inc. QIAN, CELINE X 1637 Non-Final OA 14d Pending Jan 03, 2023

Managing Gunn, Lee & Cave, P.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month